US 9776978
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
granted A61KA61K31/4245A61K31/433
Quick answer
US patent 9776978 (1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K31/4245, A61K31/433, A61K45/06, A61P